These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 13861221

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [In vitro effects of azaserine on normal and neoplastic tissue; polarographic behavior of azaserine].
    SANTAMARIA L.
    Farmaco Sci; 1955; 10(11):897-909. PubMed ID: 13294172
    [No Abstract] [Full Text] [Related]

  • 25. Antineoplastic activity of combinations of 6-chloropurine and azaserine.
    SARTORELLI AC, BOOTH BA.
    Cancer Res; 1960 Feb; 20():198-203. PubMed ID: 14441824
    [No Abstract] [Full Text] [Related]

  • 26. Inhibition of ascites tumour growth by the trypanocide, ethidium bromide, in combination with azaserine.
    KANDASWAMY TS, HENDERSON JF.
    Nature; 1962 Jul 07; 195():85. PubMed ID: 14453546
    [No Abstract] [Full Text] [Related]

  • 27. Concentrative uptake of azaserine by neoplastic plasma cells and lymphocytes.
    PINE EK.
    J Natl Cancer Inst; 1958 Nov 07; 21(5):973-84. PubMed ID: 13599021
    [No Abstract] [Full Text] [Related]

  • 28. Inhibition of the biosynthesis of purines de novo by 6-chloropurine and azaserine in sensitive and naturally resistant ascites cells.
    SARTORELLI AC, AKERS JR, BOOTH BA.
    Biochem Pharmacol; 1960 Nov 07; 5():238-44. PubMed ID: 13746609
    [No Abstract] [Full Text] [Related]

  • 29. Utilization of preformed purines by sarcoma 180 or hepatoma 134 cells treated with 6-chloropurine or a combination of 6-chloropurine and azaserine.
    SARTORELLI AC, BOOTH BA.
    Biochem Pharmacol; 1960 Nov 07; 5():245-50. PubMed ID: 13746610
    [No Abstract] [Full Text] [Related]

  • 30. HOST-TUMOR-DRUG RELATIONSHIPS IN EXPERIMENTAL CHEMOTHERAPY SYSTEMS WITH ALLOGENEIC AND XENOGENEIC HOST-TUMOR COMBINATIONS.
    TELLER MN, WOLFF R, WAGSHUL SF.
    Cancer Res; 1964 Jan 07; 24():114-9. PubMed ID: 14106153
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Adenocarcinoma of the pancreas in azaserine-treated rats.
    Longnecker DS, Curphey TJ.
    Cancer Res; 1975 Aug 07; 35(8):2249-58. PubMed ID: 1097106
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Action of azaserine on Escherichia coli.
    KAPLAN L, REILLY HC, STOCK CC.
    J Bacteriol; 1959 Oct 07; 78(4):511-9. PubMed ID: 14404400
    [No Abstract] [Full Text] [Related]

  • 38. Early cell death due to azaserine treatment of Ehrlich ascites tumor cells: a histochemical comparison of histone with DNA and total protein.
    LINDNER A.
    Acta Unio Int Contra Cancrum; 1960 Oct 07; 16():691-5. PubMed ID: 14417174
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Chemotherapy of sarcoma 180 by combinations of DL-glyceraldehyde with 6-thioguanine or with azaserine and 6-chloro-purine.
    SARTORELLI AC, SCHOOLAR EJ, KRUSE PF.
    Proc Soc Exp Biol Med; 1960 Jun 07; 104():266-8. PubMed ID: 14441826
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.